TY - JOUR
T1 - Development and dissemination of infectious disease dynamic transmission models during the COVID-19 pandemic
T2 - what can we learn from other pathogens and how can we move forward?
AU - Becker, Alexander D.
AU - Grantz, Kyra H.
AU - Hegde, Sonia T.
AU - Berube, Sophie
AU - Cummings, Derek A.T.
AU - Wesolowski, Amy
N1 - Funding Information:
AW is funded by a Career Award at the Scientific Interface by the Burroughs Wellcome Fund and the National Library of Medicine of the National Institutes of Health (award number DP2LM013102). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. All other authors declare no competing interests.
Publisher Copyright:
© 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2021/1
Y1 - 2021/1
N2 - The current COVID-19 pandemic has resulted in the unprecedented development and integration of infectious disease dynamic transmission models into policy making and public health practice. Models offer a systematic way to investigate transmission dynamics and produce short-term and long-term predictions that explicitly integrate assumptions about biological, behavioural, and epidemiological processes that affect disease transmission, burden, and surveillance. Models have been valuable tools during the COVID-19 pandemic and other infectious disease outbreaks, able to generate possible trajectories of disease burden, evaluate the effectiveness of intervention strategies, and estimate key transmission variables. Particularly given the rapid pace of model development, evaluation, and integration with decision making in emergency situations, it is necessary to understand the benefits and pitfalls of transmission models. We review and highlight key aspects of the history of infectious disease dynamic models, the role of rigorous testing and evaluation, the integration with data, and the successful application of models to guide public health. Rather than being an expansive history of infectious disease models, this Review focuses on how the integration of modelling can continue to be advanced through policy and practice in appropriate and conscientious ways to support the current pandemic response.
AB - The current COVID-19 pandemic has resulted in the unprecedented development and integration of infectious disease dynamic transmission models into policy making and public health practice. Models offer a systematic way to investigate transmission dynamics and produce short-term and long-term predictions that explicitly integrate assumptions about biological, behavioural, and epidemiological processes that affect disease transmission, burden, and surveillance. Models have been valuable tools during the COVID-19 pandemic and other infectious disease outbreaks, able to generate possible trajectories of disease burden, evaluate the effectiveness of intervention strategies, and estimate key transmission variables. Particularly given the rapid pace of model development, evaluation, and integration with decision making in emergency situations, it is necessary to understand the benefits and pitfalls of transmission models. We review and highlight key aspects of the history of infectious disease dynamic models, the role of rigorous testing and evaluation, the integration with data, and the successful application of models to guide public health. Rather than being an expansive history of infectious disease models, this Review focuses on how the integration of modelling can continue to be advanced through policy and practice in appropriate and conscientious ways to support the current pandemic response.
UR - http://www.scopus.com/inward/record.url?scp=85098858722&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85098858722&partnerID=8YFLogxK
U2 - 10.1016/S2589-7500(20)30268-5
DO - 10.1016/S2589-7500(20)30268-5
M3 - Review article
C2 - 33735068
AN - SCOPUS:85098858722
SN - 2589-7500
VL - 3
SP - e41-e50
JO - The Lancet Digital Health
JF - The Lancet Digital Health
IS - 1
ER -